<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356484</url>
  </required_header>
  <id_info>
    <org_study_id>471/14</org_study_id>
    <nct_id>NCT02356484</nct_id>
  </id_info>
  <brief_title>Surgical Stress Markers for Postoperative Complications: a Prospective Study</brief_title>
  <official_title>Predictive Value of Surgical Stress Markers for Postoperative Complications: a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the predictive value of albumine, C-reactive protein
      (CRP), procalcitonin, and lactates in terms of surgical stress and postoperative
      complications. These biomarkers will be measured from the day before surgery until
      postoperative day four in patients undergoing major surgery. Major surgery was defined as
      esophagus, gastric, liver, pancreas, endocrine, retroperitoneal, or colorectal procedures
      including an organ resection for benign or malignant disease and lasting more than 2 hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective study was conducted at the Department for Visceral Surgery at the University
      Hospital of Lausanne Switzerland (CHUV) between February and December 2015 (NCT02356484). The
      study was approved by the Institutional Review Board (No. 367/15), and all patients provided
      written consent prior to surgery. Inclusion criteria were age &gt;18 years, and elective major
      abdominal surgery—defined as an operative procedure with anticipated duration ≥2 hours.17
      Perioperative care closely adhered to recently published enhanced recovery guidelines
      (http://erassociety.org.loopiadns.com/guidelines/list-of-guidelines). Standardised fluid
      administration was followed by advanced haemodynamic monitoring to avoid intraoperative fluid
      overload. According to the clinical care pathway, intravenous fluid was typically
      discontinued the morning after surgery.

      Biological markers Serum levels of albumin, CRP, PCT and lactate (LCT) were perioperatively
      measured in a fasting state, Following standardised institutional guidelines. Blood samples
      were drawn the day before surgery, the day of surgery (4-6 hours after the end of the
      operation) and on the first, second and third postoperative day. As Baseline values tend to
      show large variations especially for albumin,4 10 we considered that a dynamic value
      (difference between two time-points) might be more informative than a snapshot value. Several
      values based on preoperative and postoperative concentrations were thus calculated for each
      marker (ie, Δ Max: maximal difference between the preoperative and postoperative values; Δ
      POD 0: difference of concentration on POD −1 and POD 0; Δ POD 1: difference of concentration
      on POD−1 and POD 1).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predictive Value of Postoperative Albumin Decrease in Terms of Surgical Stress and Postoperative Complications</measure>
    <time_frame>2 dys for Delta albumin, 30 days for postoperative complications</time_frame>
    <description>Delta albumin (g/l) before (day -1) and immediately (day 1) after surgery as a predictor of postoperative complications (until 30 days post surgery)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Operative Procedures, Complications</condition>
  <arm_group>
    <arm_group_label>Major abdominal surgery cohort</arm_group_label>
    <description>In this surgical cohort, 4 inflammatory markers were measured: albumin, procalcitonin, CRP and lactate levels</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing major surgery (esophagus, gastric, liver, pancreas, endocrine,
        retroperitoneal, or colorectal surgery)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years old

          -  Patients undergoing esophagus, gastric, liver, pancreas, endocrine, retroperitoneal,
             or colorectal surgery

          -  Operation time more than 2 hours

          -  Operation including an organ resection for benign or malignant disease

        Exclusion Criteria:

          -  Immunosuppressive therapy

          -  Cognitive impairment or language comprehension problems

          -  Absence of the consent form prior to first blood sample
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Hübner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lausanne Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Lausanne Hospital</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 1, 2015</study_first_submitted>
  <study_first_submitted_qc>February 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2015</study_first_posted>
  <results_first_submitted>December 17, 2018</results_first_submitted>
  <results_first_submitted_qc>May 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 13, 2020</results_first_posted>
  <last_update_submitted>May 1, 2020</last_update_submitted>
  <last_update_submitted_qc>May 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Nicolas DEMARTINES</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>150 inclusions planned 155 patients screened 17 refusals study stopped after 138 inclusions due to long recruitment time</recruitment_details>
      <pre_assignment_details>From the 155 patients initially eligible for the study, 17 refused to participate, thus 138 patients were included in the study</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Major Abdominal Surgery Cohort</title>
          <description>One-arm study including all patients undergoing &quot;major abdominal surgery according to the provided definition.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="138"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="138"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Major Abdominal Surgery Cohort</title>
          <description>In this surgical cohort, 4 inflammatory markers were measured: albumin, procalcitonin, CRP and lactate levels</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="138"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" lower_limit="50" upper_limit="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>demographical data such as patient gender were recorded</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Predictive Value of Postoperative Albumin Decrease in Terms of Surgical Stress and Postoperative Complications</title>
        <description>Delta albumin (g/l) before (day -1) and immediately (day 1) after surgery as a predictor of postoperative complications (until 30 days post surgery)</description>
        <time_frame>2 dys for Delta albumin, 30 days for postoperative complications</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Major Abdominal Surgery Cohort</title>
            <description>Albumin was measured preoperatively and in postoperative day 1 for all 138 study participants</description>
          </group>
        </group_list>
        <measure>
          <title>Predictive Value of Postoperative Albumin Decrease in Terms of Surgical Stress and Postoperative Complications</title>
          <description>Delta albumin (g/l) before (day -1) and immediately (day 1) after surgery as a predictor of postoperative complications (until 30 days post surgery)</description>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Major Abdominal Surgery Cohort</title>
          <description>Patients undergoing major abdominal surgery according to the provided definition</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="138"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="138"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiorespiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="138"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="138"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pr. Nicolas Demartines</name_or_title>
      <organization>Lausanne University Hospital</organization>
      <phone>0041213142424</phone>
      <email>demartines@chuv.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

